The Impact of the COVID-19 on Pfizer: Past, Present and Future

Research Article
Open access

The Impact of the COVID-19 on Pfizer: Past, Present and Future

Chengji Wu 1*
  • 1 Wuhan Britain China School    
  • *corresponding author 1811031105@mail.sit.edu.cn
Published on 13 September 2023 | https://doi.org/10.54254/2754-1169/25/20230524
AEMPS Vol.25
ISSN (Print): 2754-1177
ISSN (Online): 2754-1169
ISBN (Print): 978-1-915371-93-5
ISBN (Online): 978-1-915371-94-2

Abstract

Towards the end of 2019, COVID-19 was discovered in Wuhan, Hubei Province, China, and rapidly spread worldwide, resulting in significant impact on the global economy. Despite the pandemic being a disaster for the world, it has also created business opportunities for some healthcare companies, with Pfizer being a prime example. During the COVID-19 pandemic, Pfizer and BioNTech jointly developed Comminate, a vaccine that has been instrumental in combating the infection and death crisis. At the same time, Pfizer also engaged in the development of effective drugs. However, Pfizer has also been exposed to some negative news, which has had a significant impact on its business performance and stock price. The impact of the pandemic on Pfizer can be reflected through the changes in Pfizer's operating performance before and after the pandemic. In the future, the ever-changing factors of the COVID-19 pandemic will continue to have a certain influence on Pfizer's future, and the company will need to develop new strategies to address future challenges in order to achieve long-term stable development.

Keywords:

COVID-19, pfizer, challenge

Wu,C. (2023). The Impact of the COVID-19 on Pfizer: Past, Present and Future. Advances in Economics, Management and Political Sciences,25,335-343.
Export citation

References

[1]. Pfizer's financial performance in 2021. Pfizer's financial performance in 2021 | Pfizer 2021 Annual Report. (n.d.). Retrieved March 26, 2023, from https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2021/performance/

[2]. World Health Organization. (2023). Who coronavirus (COVID-19) dashboard. World Health Organization. Retrieved March 12, 2023, from https://covid19.who.int/

[3]. World Health Organization. (2020). Who timeline - covid-19. World Health Organization. Retrieved April 1, 2023, from https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19

[4]. GDP data of various countries in the world. GDP data of various countries in the world--Kuaiyi Data. (n.d.). Retrieved March 26, 2023, from https://www.kylc.com/stats/global/yearly_overview/g_gdp.html

[5]. China US trade - PWC CN: PricewaterhouseCoopers China. (n.d.). Retrieved March 25, 2023, from https://www.pwccn.com/zh/research-and-insights/publications/china-us-trade.pdf

[6]. Proportion of elderly population (65 and over) in the total population of each country worldwide -- Kuaiyi Data. (n.d.). Retrieved March 26, 2023, from https://www.kylc.com/stats/global/yearly_overview/g_population_65above_perc.html

[7]. What is Brexit? La Moncloa. (n.d.). Retrieved March 26, 2023, from https://www.lamoncloa.gob.es/lang/en/brexit/AboutBrexit/Paginas/index.aspx

[8]. World Health Organization. (n.d.). World Health Organization. Retrieved March 26, 2023, from https://apps.who.int/nha/database/ViewData/Indicators/en

[9]. Pfizer revenue 2010-2022: PFE. Macrotrends. (n.d.). Retrieved March 26, 2023, from https://www.macrotrends.net/stocks/charts/PFE/pfizer/revenue

[10]. PFIZER INC PFE. NYSE. (n.d.). Retrieved March 26, 2023, from https://www.nyse.com/quote/XNYS:PFE

[11]. Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study. Pfizer. (2020, November 9). Retrieved March 26, 2023, from https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

Cite this article

Wu,C. (2023). The Impact of the COVID-19 on Pfizer: Past, Present and Future. Advances in Economics, Management and Political Sciences,25,335-343.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 2023 International Conference on Management Research and Economic Development

ISBN：978-1-915371-93-5(Print) / 978-1-915371-94-2(Online)
Editor：Canh Thien Dang, Javier Cifuentes-Faura
Conference website: https://2023.icmred.org/
Conference date: 28 April 2023
Series: Advances in Economics, Management and Political Sciences
Volume number: Vol.25
ISSN：2754-1169(Print) / 2754-1177(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).

References

[1]. Pfizer's financial performance in 2021. Pfizer's financial performance in 2021 | Pfizer 2021 Annual Report. (n.d.). Retrieved March 26, 2023, from https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2021/performance/

[2]. World Health Organization. (2023). Who coronavirus (COVID-19) dashboard. World Health Organization. Retrieved March 12, 2023, from https://covid19.who.int/

[3]. World Health Organization. (2020). Who timeline - covid-19. World Health Organization. Retrieved April 1, 2023, from https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19

[4]. GDP data of various countries in the world. GDP data of various countries in the world--Kuaiyi Data. (n.d.). Retrieved March 26, 2023, from https://www.kylc.com/stats/global/yearly_overview/g_gdp.html

[5]. China US trade - PWC CN: PricewaterhouseCoopers China. (n.d.). Retrieved March 25, 2023, from https://www.pwccn.com/zh/research-and-insights/publications/china-us-trade.pdf

[6]. Proportion of elderly population (65 and over) in the total population of each country worldwide -- Kuaiyi Data. (n.d.). Retrieved March 26, 2023, from https://www.kylc.com/stats/global/yearly_overview/g_population_65above_perc.html

[7]. What is Brexit? La Moncloa. (n.d.). Retrieved March 26, 2023, from https://www.lamoncloa.gob.es/lang/en/brexit/AboutBrexit/Paginas/index.aspx

[8]. World Health Organization. (n.d.). World Health Organization. Retrieved March 26, 2023, from https://apps.who.int/nha/database/ViewData/Indicators/en

[9]. Pfizer revenue 2010-2022: PFE. Macrotrends. (n.d.). Retrieved March 26, 2023, from https://www.macrotrends.net/stocks/charts/PFE/pfizer/revenue

[10]. PFIZER INC PFE. NYSE. (n.d.). Retrieved March 26, 2023, from https://www.nyse.com/quote/XNYS:PFE

[11]. Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study. Pfizer. (2020, November 9). Retrieved March 26, 2023, from https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against

For authors
Guide for authors Policies for authors Aims and scope Subscription Open access policy
For editors
Policies for editors Editorial board
For reviewers
Policies for reviewers Privacy policy

Cookies are used by this site.
Copyright © 2024 EWA Publishing, its licensors, and contributors. All rights reserved, including text and data mining, AI training, and similar technologies.